Last Updated on June 22, 2023

Human Psychopharmacology- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: John Wiley and Sons Ltd

Abbreviation: Hum. Psychopharmacol.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

1.70

SJR

 0.449

h-Index

 84

Rank

 11356

Important Details

Title Human Psychopharmacology
Standard Abbreviation Hum. Psychopharmacol.
Type of Publication Journal
Discipline Neurology (Q3); Neurology (clinical) (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3)
Impact Score 1.70
SCImago Journal Rank (SJR) 0.449
h-index 84
Overall Rank 11356
Publisher Name John Wiley and Sons Ltd
Publication Country United Kingdom
International Standard Serial Number (ISSN) 10991077, 08856222
Coverage and History 1986-2022
Best Quartile Q3
Total Citations Received
(Last 3 Year)
200

About Human Psychopharmacology


Human Psychopharmacology is a journal published by John Wiley and Sons Ltd. This journal covers the area[s] related to Neurology, Neurology (clinical), Pharmacology (medical), Psychiatry and Mental Health, etc. The coverage history of this journal is as follows: 1986-2022. The rank of this journal is 11356. This journal's impact score, h-index, and SJR are 1.70, 84, and 0.449, respectively. The ISSN of this journal is/are as follows: 10991077, 08856222.

The best quartile of Human Psychopharmacology is Q3. This journal has received a total of 200 citations during the last three years (Preceding 2022).


Human Psychopharmacology Impact Score 2022-2023


The latest impact score (IS) of the Human Psychopharmacology is 1.70. It is computed in the year 2023 as per its definition and based on Scopus data. 1.70

It is decreased by a factor of around 0.7, and the percentage change is -29.17% compared to the preceding year 2021, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Human Psychopharmacology Impact Score 2023


Impact Score 2022 of Human Psychopharmacology is 1.70. If a similar downward trend continues, IS may decrease in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Human Psychopharmacology. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 1.70
2021 2.40
2020 1.45
2019 2.20
2018 2.27
2017 2.89
2016 2.58
2015 3.03
2014 2.64

Human Psychopharmacology h-index


  Table Setting

The h-index of Human Psychopharmacology is 84. By definition of the h-index, this journal has at least 84 published articles with more than 84 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Human Psychopharmacology ISSN


The International Standard Serial Number (ISSN) of Human Psychopharmacology is/are as follows: 10991077, 08856222.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Human Psychopharmacology Ranking and SCImago Journal Rank (SJR)


The Human Psychopharmacology is ranked 11356 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.449.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Human Psychopharmacology Publisher


Table Setting

The publisher of Human Psychopharmacology is John Wiley and Sons Ltd. The publishing house of this journal is located in the United Kingdom. Its coverage history is as follows: 1986-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Human Psychopharmacology is Hum. Psychopharmacol.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Hum. Psychopharmacol.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Human Psychopharmacology


If your area of research or discipline is related to Neurology, Neurology (clinical), Pharmacology (medical), Psychiatry and Mental Health, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Human Psychopharmacology?

The latest impact score of Human Psychopharmacology is 1.70. It is computed in the year 2023.


What is the h-index of Human Psychopharmacology?

The latest h-index of Human Psychopharmacology is 84. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Human Psychopharmacology?

The latest SCImago Journal Rank (SJR) of Human Psychopharmacology is 0.449. It is calculated in the year 2023.


What is the ranking of Human Psychopharmacology?

The latest ranking of Human Psychopharmacology is 11356. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Human Psychopharmacology?

Human Psychopharmacology is published by John Wiley and Sons Ltd. The publication country of this journal is United Kingdom.


What is the abbreviation of Human Psychopharmacology?

This standard abbreviation of Human Psychopharmacology is Hum. Psychopharmacol..


Is "Human Psychopharmacology" a Journal, Conference or Book Series?

Human Psychopharmacology is a journal published by John Wiley and Sons Ltd.


What is the scope of Human Psychopharmacology?

The scope of Human Psychopharmacology is as follows:

  • Neurology
  • Neurology (clinical)
  • Pharmacology (medical)
  • Psychiatry and Mental Health

For detailed scope of Human Psychopharmacology, check the official website of this journal.


What is the ISSN of Human Psychopharmacology?

The International Standard Serial Number (ISSN) of Human Psychopharmacology is/are as follows: 10991077, 08856222.


What is the best quartile for Human Psychopharmacology?

The best quartile for Human Psychopharmacology is Q3.


What is the coverage history of Human Psychopharmacology?

The coverage history of Human Psychopharmacology is as follows 1986-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Dermatologia Kliniczna Journal Cornetis 25442 7 0.00
European Union Politics Journal SAGE Publications Ltd 2250 72 2.64
IEEE/OSA Journal of Display Technology Journal IEEE Computer Society 12809 68 0.00
Journal of Applied Business Research Journal 23890 29 0.28
Sex Education Journal Routledge 5168 41 2.82
Physics and Chemistry of the Earth Journal Pergamon Press Ltd. 12927 33 0.00
Engenharia Agricola Journal Sociedade Brasileira de Engenharia Agricola 15839 30 1.12
Transboundary and Emerging Diseases Journal Wiley-Blackwell Publishing Ltd 4279 78 4.95
Brazilian Symposium of Computer Graphic and Image Processing Conference And Proceedings 16004 32 0.00
WSEAS Transactions on Environment and Development Journal World Scientific and Engineering Academy and Society 17731 23 1.33

Check complete list




Human Psychopharmacology Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 1.70
2021 2.40
2020 1.45
2019 2.20
2018 2.27
2017 2.89
2016 2.58
2015 3.03
2014 2.64



Top Journals/Conferences in Neurology

Lancet Neurology, The
Elsevier Ltd. | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Neuro-Oncology
Oxford University Press | United Kingdom

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

Autism in Adulthood
Mary Ann Liebert Inc. | United States

Sleep Medicine Reviews
Elsevier BV | United Kingdom

Ageing Research Reviews
Elsevier Ireland Ltd | Ireland

Stroke
American Heart Association | United States

European Stroke Journal
SAGE Publications Inc. | United States

See All

Top Journals/Conferences in Neurology (clinical)

Lancet Neurology, The
Elsevier Ltd. | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Neuro-Oncology
Oxford University Press | United Kingdom

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

Autism in Adulthood
Mary Ann Liebert Inc. | United States

Sleep Medicine Reviews
Elsevier BV | United Kingdom

Stroke
American Heart Association | United States

European Stroke Journal
SAGE Publications Inc. | United States

Annual Review of Vision Science
Annual Reviews Inc. | United States

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Drugs
Adis International Ltd | United Kingdom

Rheumatology
Oxford University Press | United Kingdom

Acta Pharmacologica Sinica
Nature Publishing Group | United Kingdom

Vaccines
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

BioDrugs
Adis International Ltd | United Kingdom

Clinical Pharmacology and Therapeutics
Wiley-Blackwell | United States

European Heart Journal - Cardiovascular Pharmacotherapy
Oxford University Press | United Kingdom

Drug and Alcohol Dependence
Elsevier Ireland Ltd | Ireland

See All

Top Journals/Conferences in Psychiatry and Mental Health

World Psychiatry
Wiley-Blackwell | United States

Lancet Psychiatry,The
Elsevier Ltd. | United Kingdom

Annual Review of Clinical Psychology
Annual Reviews Inc. | United States

JAMA Psychiatry
American Medical Association | United States

Evidence-Based Mental Health
BMJ Publishing Group | United Kingdom

Psychotherapy and Psychosomatics
S. Karger AG | Switzerland

Clinical Psychology Review
Elsevier Inc. | United States

American Journal of Psychiatry
American Psychiatric Association | United States

Journal of the American Academy of Child and Adolescent Psychiatry
Elsevier Ltd. | United Kingdom

Lancet Healthy Longevity, The
Elsevier Ltd. | United Kingdom

Molecular Psychiatry
Nature Publishing Group | United Kingdom

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

Health Psychology Review
Routledge | United Kingdom

Autism in Adulthood
Mary Ann Liebert Inc. | United States

See All